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Abstract
Background: This study aimed to explore the association of MTNR1B genetic variants with gestational plasma glucose
homeostasis in pregnant Chinese women.
Methods: A total of 1,985 pregnant Han Chinese women were recruited and evaluated for gestational glucose tolerance
status with a two-step approach. The four MTNR1B variants rs10830963, rs1387153, rs1447352, and rs2166706 which had
been reported to associate with glucose levels in general non-pregnant populations, were genotyped in these women.
Using an additive model adjusted for age and body mass index (BMI), association of these variants with gestational fasting
and postprandial plasma glucose (FPG and PPG) levels were analyzed by multiple linear regression; relative risk of
developing gestational glucose intolerance was calculated by logistic regression. Hardy-Weinberg Equilibrium was tested by
Chi-square and linkage disequilibrium (LD) between these variants was estimated by measures of D9 and r
2.
Results: In the pregnant Chinese women, the MTNR1B variant rs10830963, rs1387153, rs2166706 and rs1447352 were
shown to be associated with the increased 1 hour PPG level (p=8.04610
210, 5.49610
26, 1.89610
25 and 0.02, respectively).
The alleles were also shown to be associated with gestational glucose intolerance with odds ratios (OR) of 1.64
(p=8.03610
211), 1.43 (p=1.94610
26), 1.38 (p=1.63610
25) and 1.24 (p=0.007), respectively. MTNR1B rs1387153, rs2166706
were shown to be associated with gestational FPG levels (p=0.04). Our data also suggested that, the LD pattern of these
variants in the studied women conformed to that in the general populations: rs1387153 and rs2166706 were in high LD,
they linked moderately with rs10830963, but might not linked with rs1447352;rs10830963 might not link with rs1447352,
either. In addition, the MTNR1B variants were not found to be associated with any other traits tested.
Conclusions: The MTNR1B is likely to be involved in the regulation of glucose homeostasis during pregnancy.
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Introduction
The number of women with gestational carbohydrate intoler-
ance (abnormal oral glucose tolerance test results) including
gestational diabetes mellitus (GDM, glucose intolerance of any
degree with onset or first recognition during pregnancy) is
increasing world-wide and the prevalence varies considerably
among racial and ethnic groups [1]. Recent studies reported that
adverse maternal-fetal outcomes were observed across the
spectrum of carbohydrate intolerance including glucose values
below current cutoffs for the diagnosis of GDM [2,3]. Similarly,
both GDM and mild gestational carbohydrate intolerance in
women may lead to a high risk of metabolic syndromes related to
cardiovascular disease, type 2 diabetes, breast cancer and
dementia later on in life [3,4]. Gestational glucose abnormalities
are associated with perinatal complications and the subsequent
development of metabolic diseases. The retrospective and
prospective studies on gestational glucose metabolism, however,
are complicated as the GDM and gestational glucose intolerance
are transient phenomena resulting from transient rises in serum
PLoS ONE | www.plosone.org 1 July 2012 | Volume 7 | Issue 7 | e40113levels of the placenta hormones [5]. In addition, although several
studies have examined the association of type 2 diabetes
susceptibility loci with GDM [6,7,8,9], there is insufficient genetic
evidence for the gestational carbohydrate intolerance; and so far,
little knowledge is available regarding the predisposition of
gestational carbohydrate homeostasis in pregnant Chinese women.
Melatonin is a circulating hormone from the pineal gland and
regulates seasonal and circadian rhythms. MTNR1B belongs to
one of the functional melatonin receptor subtypes [10] and is
expressed in pancreatic islets [11]. The Genome-wide Association
Studies (GWAS) have provided strong supports for the associations
of genetic variations in the MTNR1B locus with FPG, glucose
level, insulin secretion and type 2 diabetes [11–19]. Up to now,
four MNTR1B genetic variants have been reported to be
associated with phenotypes: rs10830963 has been shown to
influence FPG in people of European descent [11,12,13] and to
be associated with type 2 diabetes in Han Chinese individuals [14];
rs1387153 has been reported to be associated with increased FPG
and risks of type 2 diabetes [15,16,17]; rs2166706 has been
demonstrated to cause rises in plasma glucose levels as well as in
the risk of type 2 diabetes in European Caucasians and Indian
Asians [18]; and rs1447352 has been found to be associated with
glucose metabolism [19]. The interrelationships between these
variants are available in HapMap database (http://hapmap.ncbi.
nih.gov). These variants are shown to be in moderate to strong LD
and the relation between LD blocks is somewhat different among
general Europeans and Chinese populations [20]. In short, the
GWAS indicate that the ‘clock’ gene may be involved in glucose
metabolism and its regulation may relate to the pathogenesis of
type 2 diabetes [21]. Since glucose intolerance in the general
population and in pregnant women share a common pathophys-
iological background and women with glucose intolerance during
pregnancy have a higher prevalence of type 2 diabetes after
pregnancy, we hypothesize that the MTNR1B genetic predisposi-
tion of gestational glucose metabolism is similar to that of the
general non-pregnant population. This study was designed to
address the possible associations between the MTNR1B genetic
variants and the gestational glucose homeostasis in a pregnant
Han Chinese population.
Materials and Methods
Study population
The study recruited 1,985 pregnant Chinese women who
received prenatal care in 17 different Hospitals of Chengdu City in
Southwest China (93.3% of all pregnant women from April 1,
2010 to April 1, 2011). All participants were Han Chinese and
resided in the metropolitan area of Chengdu. A two-step approach
based on National Diabetes Data Group (NDDG) diabetes criteria
for diagnosis of gestational abnormal glucose tolerance and GDM
was employed [22, Flowchart S1]. First, the pregnant women were
routinely offered a 50 g, 1 hour (1 h) oral glucose tolerance test at
24–28 gestational weeks for the screening glucose challenge
test(GCT), both levels of FPG and 1 h PPG were determined;
Secondly, women with FPG $5.8 mmol/l or 1 h PPG
$7.8 mmol/l in GCT and high-risk pregnant women [23] might
also be offered a 100 g, 3 h oral glucose tolerance test (OGTT);
those that had two or more abnormal values on OGTT, would be
diagnosed with GDM; and those had one value over the threshold,
would be considered to have gestational impaired glucose
tolerance (GIGT). High-risk pregnant women with FPG
$7.0 mmol/l or a random PPG $11.1 mmol/l that were
confirmed on a subsequent day would be diagnosed with GDM.
In this study, among different degree of abnormal glucose
tolerance, ABN was defined as abnormal 50 g GCT or OGTT
results except GIGT and GDM. Three women with type 1
diabetes and 4 women who had been previously diagnosed with
type 2 diabetes were excluded.
The OGTT was analyzed by a chemiluminescent immunoassay
using the ARCHITECT i2000SR System (Abbott) in the central
Clinical Isotopic Laboratory of Sichuan Provincial Hospital. The
glucose levels were measured to 0.11 mmol/l. The height and
body weight of all the recruited pregnant women were measured
to the nearest 0.1 cm and 0.1 kg, respectively. The BMI of each
participant was calculated. The gestational age was calculated
from the date of last menstrual period.
The clinical profiles of the 1,985 pregnant Chinese women are
shown in Table 1. According to the NDDG criteria, 72 women
were diagnosed with GDM (3.63%), 98 with GIGT (4.94%), 605
women with ABN (30.48%), and the remaining 1210 women with
normal glucose tolerance (NGT, 60.96%). The averaged age,
weight, BMI, and glucose levels are different between the NGT
and the GIGT/ABN & GDM groups, indicating these 2 groups
are distinct in clinical characteristics.
Ethical considerations
The written informed consent was obtained from each and
every participant. The study protocol was approved by the Review
Board of Clinical Research of the Sichuan Provincial hospital,
Maternal and Child Health Hospital of Chengdu and by the
Research & Ethics Committee of Sichuan Medical Research
Institution.
DNA extraction
Blood samples were collected as dried blood spots and total
DNA was isolated from peripheral blood lymphocytes. 1,975
(99.5%) blood samples were collected from 50 g GCT and 10
(0.5%) were from 100 g OGTT. Briefly, erythrocyte lysis buffer
was used to remove DNA-free erythrocytes, and nuclear lysis
buffer to release DNA from lymphocytes. The protein precipita-
tion solution was used to precipitate and remove protein
selectively. Finally, the purified DNA was precipitated by
isopropanol, resuspended in TE buffer and stored at 220uC for
later genotyping. Gel electrophoresis and spectrophotometric
determination were used to DNA quantification and quality
analysis. DNA samples with OD260/OD280 ratio between 1.8–
2.0 and concentration more than 50 ng/ml were used for
genotyping.
Genetic variants selection and Genotyping
We selected the 4 MTNR1B genetic variants rs10830963,
rs1387153, rs2166706 and rs1447352 for genotyping since they
had been reported to be associated with plasma glucose levels in
general populations [11–19]. The gene structure of MTNR1B and
the location of the 4 variants were shown in Figure 1A. The LD
between these variants in HapMap database showed that all 4
variants were in moderate to high LD in general populations. The
LD plots of the populations of Europeans, Han Chinese in Beijing
and Chinese in Metropolitan Denver were shown in Figure 1C, D,
E [20]. Though rs1387153 and rs2166706 were in the same LD
block at |D9|=1.00, r
2 in Chinese (.0.95) were higher than that
in Europeans (r
2=0.67). On the other hand, although rs10830963
and rs1447352 seemed to be linked with high D9, they might not
be located in the same LD block as the linkage was not perfect in
all these populations (r
2,0.45). Noticeably, rs10830963 was linked
moderately with the LD block of rs1387153 and rs2166706 by
both measures of D9 and r
2, while rs1447352 was not linked with
the LD block by measure of r
2 among these populations. We
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pregnant Chinese women studied.
These 4 variants were genotyped with an ABI PRISM 3100
Genetic Analyzer and the sequenom system at the Huada Gene
Laboratory (Shengzhen, China). The genotyping call success rate
was .98%. Among the total 1,985 samples, 100 samples were run
in duplicates with a .99% concordance rate (Quality control is
shown in Table S1).
Table 1. Comparison of Characteristics in pregnant Chinese women.
Normal
glucose
tolerance
group Abnormal glucose tolerance group
Difference of
means
between the
normal and
abnormal
groups
Classified
according to
NDDG criteria NGT(n=1210) GIGT(n=98) ABN(n=605) GDM(n=72) Total(n=1985) p_value
Age (year) 28.1163.96 30.9064.09 29.4164.07 30.5064.81 28.7364.12 ,10
26
Height (cm) 159.8664.23 158.5963.78 159.4564.26 158.4564.31 159.6164.24 0.003
Gestational week at
GCT (wk)
26.0462.23 26.1562.07 26.0462.27 26.3162.44 26.0662.29 0.08
Weight (kg) at GCT 55.6167.33 57.2969.05 56.3568.21 58.56610.16 56.0267.82 0.007
Weight (kg)
before delivery
65.4868.14 68.00610.00 65.7268.55 68.57612.04 65.7568.52 0.19
BMI (kg/m
2)
at GCT
21.7662.77 22.7763.39 22.1763.03 23.1163.77 21.9862.94 0.0001
BMI (kg/m
2)
before delivery
25.5563.06 26.7163.64 25.8663.12 27.5664.20 25.7563.17 0.007
Fasting plasma
glucose level (mmol/l)
4.6060.54 5.3060.71 4.9760.0.61 5.6461.43 4.7860.68 ,10
26
postprandial
1 hour plasma
glucose level
(mmol/l)
6.3660.85 9.4061.03 8.7660.94 10.2861.83 7.3861.61 ,10
26
Data are presented as (mean 6 SD).
doi:10.1371/journal.pone.0040113.t001
Figure 1. The MTNR1B gene structure and Haploview plot for 4 MTNR1B variants. The MTNR1B gene structure with the location of the
variants studied (A) and pairwise D9 Haploview plot for the 4 MTNR1B variants was shown; R-squared was also displayed for LD values. B. based on our
data for glucose tolerance status in pregnant Chinese women. C. Europeans. D. Han Chinese in Beijing. E. Chinese in Metropolitan Denver. 88668 mm
(6006600DPI).
doi:10.1371/journal.pone.0040113.g001
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Pearson’s Chi-square was conducted in pregnant Han Chinese
women to test for Hardy-Weinberg equilibrium of each variant.
The allelic and genotypic frequencies of all the 4 variants were in
Hardy-Weinberg equilibrium (HWE p-values were showed in
Table S1).
Statistical power for correlation and regression analysis was
calculated by G*Power3.1 [24]. The levels of FPG and 1 h PPG
from 50 g GCT were used for genetic analyses in the study. For
FPG analysis, with the effect size of 0.068, 0.068, 0.07, and
0.065 mmol/l per allele under an additive genetic model
according to previous researches in Europeans for rs10830963,
rs1387153, rs2166706 and rs1447352, respectively [11,18,16,19],
our total sample size of 1,985 would have over 80% statistical
power with a type I error rate of 0.05. Power calculation for PPG
analysis, we used the effect size .0.1 mmol/l per allele based on
our data. And statistical power of logistic regression was calculated
by Power for Genetic Association software [25]. The prevalence of
gestational glucose intolerance was calculated at 39%, with risk
allele frequencies of 0.41, 0.58, 0.42 and 0.31 for rs10830963 G,
rs2166706 T, rs1387153 T, and rs1447352 G allele according to
previous researches in Han Chinese in Beijing, respectively, odds
ration of 1.64, 1.40, 1.45 and 1.26, also for respective variants.
Using these parameters, it was calculated that our sample size of
775 abnormal glucose level cases and 1,210 controls would have
over 95% statistical power with a type I error rate of 0.05.
Linkage between these variants was calculated by the Haplo-
view v4.1 software downloaded from website of the Broad Institute
http://www.broadinstitute.org/mpg/haploview [26].
Under the additive model with adjustment of age and BMI,
multivariate linear regression was performed to detect association
between the polymorphisms and the gestational plasma glucose
levels in all the pregnant Han Chinese women; to examine residual
association of the outcome with the other variants, conditional
analysis was carried out on the strongest signal in univariate
analysis. Logistic regression analysis was utilized to evaluate the
relative risk of gestational glucose intolerance of various degrees.
In particular, since women with mildly elevated glucose levels also
demonstrate a risk of metabolic syndromes and adverse outcomes,
and an abnormal GCT in pregnancy, even followed with a normal
OGTT, predicted risks of adverse obstetrical outcomes and
metabolic dysfunction [27], we combined GIGT/ABN and
GDM women into one abnormal group; thus, we divided the
pregnant Chinese women into two groups: the normal group
including all women with a regular result in any glucose tolerance
tests and the abnormal group consisting of the women with various
degrees of glucose intolerance including GIGT/ABN & GDM.
These statistical analyses were performed using STATA software,
2011 release (StataCorp, USA).
Statistical significance was defined as p,0.05. For multiple
corrections, p-values were not corrected.
Results
Association between MTNR1B and gestational glucose
levels
Table 2 summarizes the associations of the MTNR1B variants
with the gestational glucose levels in the pregnant Chinese women.
For FPG, rs1387153 and rs2166706 were shown to be associated
with gestational FPG levels (p,0.05), whereas rs10830963 and
rs1447352 were not found to be significantly associated with FPG
levels. But interestingly, the mean level of FPG in women with
each additional risk alleles for each variant was higher than those
without risk alleles. For PPG, each additional risk allele increased
the levels of PPG. For example, each additional G risk allele of
rs10830963 significantly increased the PPG level (CC, CG and
GG were found to have a mean PPG levels of 7.03 to 7.44 and
7.90 mmol/l, respectively). After adjusting for age and BMI,
under the additive genetic model, each G allele of rs10830963 was
found to be associated with an increased PPG level of 0.33 mmol/l
(95% CI 0.23, 0.44, p=8.04610
210). Analyses of repeat regression
after conditioning on rs10830963 revealed that each G allele was
associated with an increased PPG level of 0.43 mmol/l (95% CI
0.33, 0.53, p=2.59610
216). Also, a risk allele of rs1387153 T,
rs2166706 T and rs1447352 A was found to be significantly
associated of with an increased PPG level (p=5.49610
26,
1.89610
25 and 0.03, respectively), whereas no association was
found between the MTNR1B variants and the other traits tested
such as weight, BMI or age.
Association between MTNR1B variants and gestational
glucose intolerance
We further analyzed the genetic association of MTNR1B
variants for the risk of plasma glucose intolerance between the
NGT and the abnormal groups including GIGT/ABN & GDM.
The minor alleles of rs10830963 and rs1387153, and the major
alleles of rs2166706 and rs1447352 were found to be associated
with the gestational glucose intolerance under the additive genetic
model (Table 2). In particular, the frequency of the risk allele G of
rs10830963 was much higher in the gestational glucose intolerance
group compared to that of the normal group (48.43% vs. 36.81%);
adjustments for age and BMI yielded an OR of 1.64 (95% CI 1.41,
1.90) with p=8.03610
211. Also, the risk alleles of rs1387153 T
and rs2166706 T displayed higher frequencies in the glucose
intolerance pregnant women than those in the normal ones
(46.26% vs. 39.12% and 60.81% vs. 54.20%, respectively). The
MTNR1B variant rs1447352 was observed to have less influence
on glucose intolerance than the other variants in this study.
LD Structure Comparison
We compared the LD structure of these MTNR1B variants
among the Europeans, Han Chinese in Beijing, Chinese in
Metropolitan Denver and the studied pregnant population
(Figure 1). The results indicated that the LD pattern in the
studied women conformed to that in general populations:
rs1387153 and rs2166706 were in the same LD block with each
other (|D9|=0.98, r
2=0.96 in the studied women); Also,
although rs10830963 and rs1447352 have high |D9| (=0.96 in
the studied women), the 2 variants might not be in the same LD
block with each other as the r
2 was very low (=0.29 in the studied
women); Similar to that of general population, rs10830963 was
moderately linked with the LD block of rs1387153 and rs2166706
by both measures of |D9| and r
2, but rs1447352 was not linked
with the LD block by measure of r
2 in the studied women. The
relation among these 4 variants in the studied women was very
close to that of Chinese in Metropolitan Denver, as the studied
women and Chinese in Metropolitan Denver may mainly consist
of both South and North origin Chinese people, whereas, Han
Chinese in Beijing are mainly north origin.
Discussion
This study revealed that the 4 MTNR1B genetic variations,
which were previously reported to be associated with glucose
homeostasis in general populations, were associated with the
gestational postprandial glucose level and with the glucose
intolerance of various degrees in the pregnant Han Chinese
women. Both rs1387153 and rs2166706 were found to be tightly
Associations of MTNR1B with Gestational Glucose
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gestational plasma glucose levels. The G allele of rs10830963 was
shown to be the strongest signal to associate with the increased
PPG level and abnormal glucose tolerance. However, rs1447352
was not found to be strongly associated with gestational glucose
levels and glucose intolerance. In both general populations and
our studied pregnant cohort, the rs1447352 has high values of D9
with the other 3 variants, especially with rs10830963, but the
values of r
2 between rs1447352 and these variants were lower than
0.30 which indicated that rs1447352 might not be really linked
with these variants. Also, the different degrees of the association
are probably related to the variant’s different location in the gene.
The variant rs1387153 and rs2166706 located at the .11 kb
upstream of the MTNR1B gene, rs10830963 is intronic, whereas
rs1447352 located at the ,4.5 kb downstream of the gene
(Figure 1A). Currently little knowledge about their role and
regulation of MTNR1B gene expression is available. It is well
known that gene upstream sequences and introns have various
important regulatory functions, for example, intron-derived
miRNAs are able to induce RNA interference. Hence it is
intriguing for further research on how these different variants
affect the gene function, especially in the gestational background.
Based on GWAS, there are reports about that the G-allele of
MTNR1B rs10830963 associated with defective early insulin
response, beta-cell dysfunction and hepatic insulin resistance in
Europeans [13,14], and Lyssenko et al. have showed the
pathogenic effects of MTNR1B were likely exerted via a direct
inhibitory effect on beta cell [12], the particular physiological
pathway of MTNR1B in glucose metabolism has not been
identified, yet it is interesting that the genetic variants within the
MTNR1B region have different influence on glucose levels during
pregnancy. Considering the importance of biological rhythms for
metabolic regulation and the reciprocal influence of gestational
hormones, the link between the MTNR1B susceptibility loci and
gestational glucose metabolism may reveal new mechanisms
underlying glucose homeostasis during pregnancy.
In pregnant Chinese women, we observed that rs1387153 and
rs2166706 were associated with gestational FPG levels, but we
could not detect a significant association between the MTNR1B
variants rs10830963, rs1447352 and the gestational FPG levels in
the regression analysis. Nevertheless, we observed that for each
MTNR1B variant with each additional risk alleles, the mean levels
of FPG were higher than those without the risk alleles in the
studied women. It is also noteworthy that in the current study, the
effect size of FPG in pregnant women was less than that reported
in the general populations. In fact, FPG levels tend to decrease
during pregnancy, likely due to the effect of pregnant hormones on
blood glucose and insulin resistance. Our data indicate that
MTNR1B genetic polymorphisms could be associated with
gestational FPG levels in the pregnant Chinese women.
In this study, both levels of FPG and PPG were normally
distributed (Figure S1); the allelic and genotypic frequencies of all
the 4 studied variants were in Hardy-Weinberg equilibrium (Table
S1); and the result of LD tests in these pregnant women was
concordant with the LD pattern in the general population [20].
Since the studied sample population of pregnant women was
limited to Chengdu in China, it will be necessary to confirm our
findings through studies of populations of other districts and
ethnicities. Interestingly, MTNR1B rs10830963 and rs1387153
were reported to be linked to the risk of GDM in Korean women
[28], as well, rs10830963 was recently found to be associated with
beta-cell function in a Chinese pregnant Population [29], although
both studies did not test the association of the MTNR1B variants
with different gestational glucose levels and glucose intolerance.
In summary, our data suggests that the genetic variants within
MTNR1B gene are associated with gestational glucose levels and
gestational glucose intolerance. To our knowledge, this is the first
report on the association in a cohort of pregnant Chinese women.
This work extended the research on MTNR1B from the general
population into the context of pregnancy and provided new
information on associations of MTNR1B polymorphisms in the
Chinese population.
Supporting Information
Figure S1 Histogram of fasting and 1 hour postprandial
glucose levels. Both levels of FG & 1 h PPG (fg & p1hrs) in the
1,985 pregnant Chinese women at 24–28 gestational weeks were
normally distributed.
(TIF)
Table S1 Quality control results of the variants and the p-value
for Hardy-Weinberg Equilibrium.
(DOC)
Flowchart S1 Screening for gestational glucose intolerance in
pregnant Chinese women. Briefly, a stepwise approach for all
pregnant women was used. Step 1 is a screening 50 g, 1 h glucose
challenge test, both the fasting glucose and the 1 hour postpran-
dial glucose levels were determined. Women with FPG
$5.8 mmol/l or 1 h PPG $7.8 mmol/l were defined as a positive
GCT result and would be suggested to go to step 2. Step 2 is a
100 g, 3 h OGTT. NDDG cut-off for diagnosis GDM was
employed. The high-risk pregnant women with demonstrable risk
factors might be suggested to undergo a random blood glucose test
at the first antenatal visit. If they had FPG $7.0 mmol/l or a
random PPG $11.1 mmol/l, and this result was confirmed on a
subsequent day, the women would be diagnosed with GDM or
DM (T1DM and previous T2DM with elevated HgA1C prior to
20 gestational weeks) without diagnostic OGTT. There were 1992
pregnant women who agreed to join the study. 196 women with
high risk factors of diabetes, together with 1779 women underwent
50 g GCT. Among these women, 1209 women were negative in
GCT; only 1 woman was later rescreened for 100 g OGTT due to
suspected macrosomia. The other 766 women were positive in
GCT, 4 of them were confirmed with fg.7 mmol/l or
pg.11 mmol/l. Although the rest 762 women with positive
GCT were suggested to undergo 100 g OGTT, 654 women
actually underwent 100 g OGTT. Among these 654 women, 349
women were positive in 100 g OGTT result. In detail, 72 of these
349 women were GDM according to NDDG diabetes criteria, 5
were GIGT and 113 were just abnormal in one glucose level
without reaching the thresholds. For the other women with high
risk factors of diabetes, 7 women (T1DM and T2DM) were
excluded from the current study, and 9 women directly underwent
100 g OGTT, 2 of these 9 women were normal in 100 g OGTT
result.
(DOC)
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